drugset
drugset / Trial / NCT02080780

Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects

NCT02080780 ↗

Phase 1 Completed 24 enrolled Ventrus Biosciences, Inc TKL Research, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the drug-drug interaction potential of clarithromycin XL on Diltiazem hydrochloride (DTZ) 2% cream.

Timeline

Start
2013-09
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule 1000 mg Oral
Subject Diltiazem Small molecule 8.5 mg Topical

Indications

No indication recorded.